Cincinnati, OH, United States of America

Brenna Carey

This inventor holds 1 USPTO granted patent. Top assignee: Cincinnati Children's Hospital Medical Center. Active years: 2019.


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Brenna Carey: Innovator in Lung Disorder Treatments

Introduction

Brenna Carey is a notable inventor based in Cincinnati, OH (US). She has made significant contributions to the field of medical research, particularly in the treatment of lung disorders. Her innovative work focuses on addressing conditions characterized by cholesterol dysregulation.

Latest Patents

Brenna Carey holds 1 patent for her invention titled "Composition and methods for treatment of lung disorders characterized by cholesterol dysregulation." This patent discloses compositions and methods for treating conditions associated with dysregulation in macrophage lipid homeostasis. The methods may include the administration of agents such as a PPARγ agonist, a LXR agonist, or a combination of both. These methods aim to prevent, treat, or ameliorate conditions like pulmonary alveolar proteinosis (PAP) and related symptoms.

Career Highlights

Brenna is affiliated with Cincinnati Children's Hospital Medical Center, where she conducts her research and develops her innovative treatments. Her work has the potential to significantly impact the lives of patients suffering from lung disorders.

Collaborations

Brenna collaborates with esteemed colleagues, including Bruce C. Trapnell and Takuji Suzuki, who contribute to her research efforts and enhance the scope of her work.

Conclusion

Brenna Carey is a pioneering inventor whose research in lung disorder treatments showcases her dedication to improving patient outcomes. Her innovative approaches and collaborations highlight the importance of continued research in this critical area of healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…